Personal Finance

Why Allscripts Healthcare Solutions Stock Is Rising Today

Doctor using laptop

What happened

Shares of Allscripts Healthcare Solutions (NASDAQ: MDRX) , an information technology company focused on the healthcare industry, are up 11% as of 11:30 a.m. EDT. The double-digit gain is attributable to its release of mostly positive second-quarter results.

So what

Here's a review of the key takeaways from the quarter:

  • Non- GAAP revenue increased 25% to $536 million. That was shy of the $538.2 million in revenue what Wall Street had projected.
  • Non-GAAP earnings per share grew 20% to $0.18. That figured matched market watchers' projection.
  • Contract revenue backlog increased 16% to $4.8 billion.
  • Non-GAAP gross margin fell by 100 basis points to 47%.
  • Stock buybacks totaled $44 million in the quarter. The company's board authorized a brand new $250 million buyback program.
Doctor using laptop

Image source: Getty Images.

Mangement also reaffirmed its financial outlook for the year:

  • Non-GAAP revenue is expected to climb at least 17% to a range of $2.15 billion to $2.25 billion.
  • Adjusted EBITDA is expected to grow at least 12% to a range of $420 million to $460 million.
  • Non-GAAP EPS is expected to increase at least 16% to a range of $0.72 to $0.82.

These figures line up well with Wall Street's estimate of $2.18 billion in total revenue and $0.77 in EPS.

Investors are bidding up the stock price in response to the generally positive results.

Now what

Allscripts Healthcare Solutions has badly underperformed the market over the last several years, so today's pop should come as welcome relief to its shareholders.

SPY data by YCharts .

Looking ahead, Wall Street projects that the company's profits will grow in excess of 18% annually over the next five years. If that number proves to be anywhere close to reality, then the stock's current valuation of about 16 times next year's earnings estimates could prove to be attractive. However, given the company's poor track record of creating shareholder value, I thinks that approaching this stock with a wait-and-see mind-set makes the most sense. Investors who are interested in the healthcare information service stocks might want to considerlooking elsewhere .

10 stocks we like better than Allscripts

When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor , has quadrupled the market.*

David and Tom just revealed what they believe are the 10 best stocks for investors to buy right now... and Allscripts wasn't one of them! That's right -- they think these 10 stocks are even better buys.

Click here to learn about these picks!

*Stock Advisor returns as of June 4, 2018

Brian Feroldi has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy .

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story


Other Topics


Latest Personal Finance Videos

    #TradeTalks: The Changing E-Commerce Landscape

    e-Commerce Consultant James Thomson joins Jill Malandrino on Nasdaq #TradeTalks to discuss the changing e-commerce landscape, what consumers should prepare for as we head into shopping season and why you shouldn’t do last minute shipping.

    5 hours ago

    The Motley Fool

    Founded in 1993 in Alexandria, VA., by brothers David and Tom Gardner, The Motley Fool is a multimedia financial-services company dedicated to building the world's greatest investment community. Reaching millions of people each month through its website, books, newspaper column, radio show, television appearances, and subscription newsletter services, The Motley Fool champions shareholder values and advocates tirelessly for the individual investor. The company's name was taken from Shakespeare, whose wise fools both instructed and amused, and could speak the truth to the king -- without getting their heads lopped off.

    Learn More